Creative Medical Technology Holdings (CELZ) Notes Payables (2010 - 2023)

Creative Medical Technology Holdings (CELZ) has reported Notes Payables for 14 consecutive years, with $14194.0 the latest figure, recorded in Q1 2023.

• On a quarterly basis, Notes Payables changed 0.0% year-over-year to $14194.0 in Q1 2023; TTM through Mar 2023 was $14194.0, a 0.0% change from a year earlier, with the FY2022 full-year figure at $14194.0, changed 0.0% from the prior year.
• Notes Payables was $14194.0 for Q1 2023 at Creative Medical Technology Holdings, roughly flat from $14194.0 in the prior quarter.
• Over five years, Notes Payables peaked at $38.7 million in Q4 2020 and troughed at $14194.0 in Q4 2021.
• A 5-year average of $3.7 million and a median of $1.6 million in 2020 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables surged 465.75% in 2020 and sank 99.96% in 2021, its largest moves.
• Over 5 years, Notes Payables stood at $6.8 million in 2019, then surged by 465.75% to $38.7 million in 2020, then slumped by 99.96% to $14194.0 in 2021, then changed by 0.0% to $14194.0 in 2022, then changed by 0.0% to $14194.0 in 2023.
• The last three Notes Payables figures came in at $14194.0 (Q1 2023), $14194.0 (Q4 2022), and $14194.0 (Q3 2022), per Business Quant data.